发布求助
文献互助 智能选刊 最新文献

The Journal of nuclear medicine and allied sciences最新文献

筛选
英文 中文
Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas. 胃肠道腺癌患者血清中TAG-72和CEA肿瘤标志物的评价。
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
F Guadagni, M Roselli, T Amato, M R Abbolito, M Cosimelli, E Mannella, J W Greiner, J Schlom
{"title":"Evaluation of TAG-72 and CEA tumor markers in sera of patients with gastrointestinal adenocarcinomas.","authors":"F Guadagni, M Roselli, T Amato, M R Abbolito, M Cosimelli, E Mannella, J W Greiner, J Schlom","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4 Suppl","pages":"293-6"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13247426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Echography and CA 125 in ovarian pathology. Preliminary data of a new score. 超声和ca125在卵巢病理中的应用。新评分的初步数据。
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
M Foglia, P G Verri, A Calabrese, F Corongiu, A Tarani, M L Margiaria, A De Pascale, D Tagliati
{"title":"Echography and CA 125 in ovarian pathology. Preliminary data of a new score.","authors":"M Foglia, P G Verri, A Calabrese, F Corongiu, A Tarani, M L Margiaria, A De Pascale, D Tagliati","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4 Suppl","pages":"67-70"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13247438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analytical contribution of CEA MEIA IMX]. [CEA MEIA IMX的分析贡献]。
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
S Bonjean, M Cristoferi, S Ratibondi
{"title":"[Analytical contribution of CEA MEIA IMX].","authors":"S Bonjean, M Cristoferi, S Ratibondi","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4 Suppl","pages":"261-70"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13247570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between CEA and GICA in patients with advanced cancer. 晚期肿瘤患者CEA与GICA的比较。
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
L Camogliano, R Massacane, M L Goggi, M D'Ulizia, C Arfini, M Masino, E Priarone, M Tacchino
{"title":"Comparison between CEA and GICA in patients with advanced cancer.","authors":"L Camogliano, R Massacane, M L Goggi, M D'Ulizia, C Arfini, M Masino, E Priarone, M Tacchino","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4 Suppl","pages":"289-90"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13247577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of serum CA549, CA M26 and CA M29 levels in the post-operative follow-up of breast cancer patients. 乳腺癌患者术后随访血清CA549、CA M26、CA M29水平的评价
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
A Nicolini, M Ferdeghini, C Colombini, A Carpi
{"title":"Evaluation of serum CA549, CA M26 and CA M29 levels in the post-operative follow-up of breast cancer patients.","authors":"A Nicolini,&nbsp;M Ferdeghini,&nbsp;C Colombini,&nbsp;A Carpi","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In a group of breast cancer patients post-operatively followed-up by serum CEA, TPA, and CA15-3 level determinations, the CA549, CA M26 and CA M29 values as well were measured. In metastatic patients, CA549 and CA M26 showed a sensitivity only slightly lower (70% and 67%, respectively) than that of TPA which was the highest (78%), while CA M29 sensitivity (58%) was much lower than that of TPA and similar to CEA (57%). In non-relapsed patients, CA M26 and CA M29 showed a specificity (95% and 92% respectively) similar to CEA (86%) and CA15-3 (92%) and much higher than TPA (73%). Among the possible associations of all the studied tumor markers, the CA M26-CA M29-CEA one seems the most promising because of its high sensitivity and specificity. Benign liver diseases and/or diabetes are probably the reasons most often responsible for the aspecific increase in serum CA549 values. On the other hand, they seem to affect the CA M29 much less and the CA M26 almost not at all.</p>","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4","pages":"309-13"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13246258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Tyrosine-phosphorylated proteins in human breast carcinoma]. [人乳腺癌中酪氨酸磷酸化蛋白]。
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
S Bretti, A P Cappa, P M Comoglio, M F Di Renzo
{"title":"[Tyrosine-phosphorylated proteins in human breast carcinoma].","authors":"S Bretti,&nbsp;A P Cappa,&nbsp;P M Comoglio,&nbsp;M F Di Renzo","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Proteins phosphorylated on tyrosine are detectable by antibodies against phosphotyrosine (P-Tyr antibodies) in cells transformed by oncogene-encoded tyrosine kinases. We used P-Tyr antibodies to investigate the existence of abnormal levels of phosphoproteins in human breast cancer. Three human breast cancer cell lines (SK-BR-3, MCF-7 and CG-5) and 37 human breast cancer specimens were examined by Western blot analysis and \"in vitro\" kinase assay. In the SK-BR-3 cell line three major phosphoproteins of the approximate Mr of 185,000 (p185), 135,000 (p135) and 110,000 (p110) were detected. The former was identified as the HER-2 gene product by specific antibodies against HER-2 encoded protein. In the other cell lines, a product of the approximate Mr of 170,000 (p170), together with a p135 and a p110, were phosphorylated on tyrosine. P185 and p170 were shown to have an associated tyrosine kinase activity. Two proteins, comigrating with p135 and p110, were found to be highly phosphorylated on tyrosine in 50% of the breast cancer samples, but not in samples harvested from 12 human tumors of the gastro-intestinal tract. These data show that 50% of human breast cancer samples display an abnormal level of tyrosine phosphorylated proteins.</p>","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4 Suppl","pages":"205-10"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"12873319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Soluble interleukin-2 receptor: a new prognostic marker in lung cancer. 可溶性白介素-2受体:肺癌新的预后指标。
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
P Marino, G Buccheri, A Preatoni, D Ferrigno, P Cori, A Rosti, R Mozzi, G A Moroni
{"title":"Soluble interleukin-2 receptor: a new prognostic marker in lung cancer.","authors":"P Marino,&nbsp;G Buccheri,&nbsp;A Preatoni,&nbsp;D Ferrigno,&nbsp;P Cori,&nbsp;A Rosti,&nbsp;R Mozzi,&nbsp;G A Moroni","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4 Suppl","pages":"151-4"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13246899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast cancer and tumor markers. 乳腺癌和肿瘤标志物。
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
E Castellaro, S Francioni, M Pastore
{"title":"Breast cancer and tumor markers.","authors":"E Castellaro,&nbsp;S Francioni,&nbsp;M Pastore","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4 Suppl","pages":"43-7"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13247435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of MCA and CA 15-3 in tissue and in serum of patients with breast carcinoma: preliminary results. 乳腺癌患者组织和血清中MCA和ca15 -3的评价:初步结果。
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
G Reale, M R Giovagnoli, A Vecchione, L Cosentino, F Benci, A Manna, G Marchei, I Vittori, L Frati
{"title":"Evaluation of MCA and CA 15-3 in tissue and in serum of patients with breast carcinoma: preliminary results.","authors":"G Reale,&nbsp;M R Giovagnoli,&nbsp;A Vecchione,&nbsp;L Cosentino,&nbsp;F Benci,&nbsp;A Manna,&nbsp;G Marchei,&nbsp;I Vittori,&nbsp;L Frati","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4 Suppl","pages":"53"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13247436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interleukin 2 soluble receptor (s-IL 2R) and lung cancer. 白细胞介素2可溶性受体(s-IL 2R)与肺癌。
The Journal of nuclear medicine and allied sciences Pub Date : 1990-10-01
F Pecchio, M Rapellino, G Aimo, S Baldi, M Cunazza, D Libertucci, A Cavallo, A Oliaro, R Pagni
{"title":"Interleukin 2 soluble receptor (s-IL 2R) and lung cancer.","authors":"F Pecchio,&nbsp;M Rapellino,&nbsp;G Aimo,&nbsp;S Baldi,&nbsp;M Cunazza,&nbsp;D Libertucci,&nbsp;A Cavallo,&nbsp;A Oliaro,&nbsp;R Pagni","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76654,"journal":{"name":"The Journal of nuclear medicine and allied sciences","volume":"34 4 Suppl","pages":"163-7"},"PeriodicalIF":0.0,"publicationDate":"1990-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"13247554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书